Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia
NCT07120607
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
9
Enrollment
OTHER_GOV
Sponsor class
Conditions
Leukemia
Interventions
BIOLOGICAL:
CD7 CAR-γδT cell（QH106）
DRUG:
Fludarabine (FLU)
DRUG:
Cyclophosphamide (CTX)
Sponsor
Anhui Provincial Hospital